Heufelder Jens, Cordini Dino, Fuchs Hermann, Heese Jürgen, Homeyer Heinrich, Kluge Heinz, Morgenstern Hans, Höcht Stefan, Nausner Martin, Bechrakis Nikolaos E, Hinkelbein Wolfgang, Foerster Michael H
Hahn-Meitner-Institut Berlin, Augentumortherapie.
Z Med Phys. 2004;14(1):64-71. doi: 10.1078/0939-3889-00190.
Eye tumors (choroidal melanomas, iris melanomas, and choroidal hemangiomas) are being treated with 68 MeV protons since 1998 at the Ion Beam Laboratory of the Hahn-Meitner Institute of Berlin (Germany's first proton therapy center), in cooperation with the Charité University Hospital in Berlin, Campus Benjamin Franklin. The proton beam, generated via a combination of Van de Graaff accelerator and cyclotron, is prepared by passive shaping for conformal tumor irradiation. A digital X-ray verification of the tumor location with the patient in sitting position limits the position uncertainties to a maximum of 0.3 mm. The treatment planning is performed using the program EYEPLAN. OCTOPUS, a CT-based planning program developed in cooperation with the German Cancer Research Center of Heidelberg, is under pre-clinical testing. Thus far, more than 400 patients have been irradiated. The first results are comparable to those obtained in other proton therapy centers. At the end of 2002, the University Hospital of Essen has also become a cooperation partner of the Hahn-Meitner Institute.
自1998年以来,德国柏林哈恩-迈特纳研究所的离子束实验室(德国首个质子治疗中心)与柏林夏里特大学医院本杰明·富兰克林校区合作,使用68兆电子伏特的质子治疗眼部肿瘤(脉络膜黑色素瘤、虹膜黑色素瘤和脉络膜血管瘤)。通过范德格拉夫加速器和回旋加速器组合产生的质子束,经被动塑形后用于适形肿瘤照射。患者坐姿时对肿瘤位置进行数字X射线验证,将位置不确定性限制在最大0.3毫米。治疗计划使用EYEPLAN程序进行。与海德堡德国癌症研究中心合作开发的基于CT的计划程序OCTOPUS正在进行临床前测试。到目前为止,已有400多名患者接受了照射。初步结果与其他质子治疗中心的结果相当。2002年底,埃森大学医院也成为哈恩-迈特纳研究所的合作方。